Pediatric Mechanical Circulatory Support

  • Katherine Cashen
  • Swati Sehgal
  • Henry L. WaltersIII
Chapter

Abstract

Extracorporeal life support (ECLS) via extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs) has evolved as a therapeutic treatment option for the care of children with severe ventricular dysfunction, refractory to medical and/or surgical therapy. The American Heart Association currently includes ECLS in both the pediatric and the adult algorithms for refractory shock. In this chapter, we review indications for ECLS initiation, history, basic principles and management strategies, complications, and outcomes.

Keywords

Extracorporeal life support (ECLS) Extracorporeal membrane oxygenation (ECMO) Ventricular assist device (VAD) Heart failure Acquired heart disease Congenital heart disease 

Notes

Conflicts of Interest

Disclosures: The authors have not disclosed any potential conflicts of interest.

Selected Reading

  1. 1.
    de Caen AR, Maconochie IK, Aickin R, et al. Part 6: pediatric basic life support and pediatric advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2015;132(16 Suppl 1):S177–203.CrossRefGoogle Scholar
  2. 2.
    Bergmann KR, Kharbanda A, Haveman L. Myocarditis and pericarditis in the pediatric patient: validated management strategies. Pediatr Emerg Med Pract. 2015;12(7):1–22.PubMedGoogle Scholar
  3. 3.
    Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med. 2011;12(3):277–81.CrossRefGoogle Scholar
  4. 4.
    Polito A, Barrett CS, Wypij D, et al. Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med. 2013;39(9):1594–601.CrossRefGoogle Scholar
  5. 5.
    ELSO. Registry of the extracorporeal life support organization. Ann Arbor, MI: ELSO; 2017. http://www.elsonet.org. Accessed 25 Apr 2017.
  6. 6.
    Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867–76.CrossRefGoogle Scholar
  7. 7.
    Adachi I, Burki S, Zafar F, Morales DL. Pediatric ventricular assist devices. J Thorac Dis. 2015;7(12):2194–202.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Fuchs A, Netz H. Ventricular assist devices in pediatrics. Images Pediatr Cardiol. 2001;3(4):24–54.Google Scholar
  9. 9.
    Almond CS, Morales DL, Blackstone EH, et al. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation. 2013;127(16):1702–11.CrossRefGoogle Scholar
  10. 10.
    Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535–41.CrossRefGoogle Scholar
  11. 11.
    Rosenthal DN, Almond CS, Jaquiss RD, et al. Adverse events in children implanted with ventricular assist devices in the United States: data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016;35(5):569–77.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Katherine Cashen
    • 1
  • Swati Sehgal
    • 2
  • Henry L. WaltersIII
    • 3
  1. 1.Department of Pediatrics, Division of Critical Care Medicine, Children’s Hospital of MichiganWayne State University School of MedicineDetroitUSA
  2. 2.Department of Pediatrics, Division of Cardiology, Children’s Hospital of MichiganWayne State University School of MedicineDetroitUSA
  3. 3.Department of Cardiovascular Surgery, Children’s Hospital of Michigan, FTAWayne State University School of MedicineDetroitUSA

Personalised recommendations